CDIO
Price
$1.36
Change
-$3.19 (-70.11%)
Updated
Feb 3 closing price
Capitalization
2.48M
Intraday BUY SELL Signals
GLMD
Price
$0.67
Change
-$0.88 (-56.77%)
Updated
Feb 3 closing price
Capitalization
3.67M
56 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CDIO vs GLMD

Header iconCDIO vs GLMD Comparison
Open Charts CDIO vs GLMDBanner chart's image
Cardio Diagnostics Holdings
Price$1.36
Change-$3.19 (-70.11%)
Volume$101.97K
Capitalization2.48M
Galmed Pharmaceuticals
Price$0.67
Change-$0.88 (-56.77%)
Volume$35.85K
Capitalization3.67M
CDIO vs GLMD Comparison Chart in %
CDIO
Daily Signal:
Gain/Loss:
GLMD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CDIO vs. GLMD commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDIO is a Hold and GLMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (CDIO: $1.36 vs. GLMD: $0.67)
Brand notoriety: CDIO and GLMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDIO: 18% vs. GLMD: 32%
Market capitalization -- CDIO: $2.48M vs. GLMD: $3.67M
CDIO [@Biotechnology] is valued at $2.48M. GLMD’s [@Biotechnology] market capitalization is $3.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDIO’s FA Score shows that 0 FA rating(s) are green whileGLMD’s FA Score has 1 green FA rating(s).

  • CDIO’s FA Score: 0 green, 5 red.
  • GLMD’s FA Score: 1 green, 4 red.
According to our system of comparison, both CDIO and GLMD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDIO’s TA Score shows that 4 TA indicator(s) are bullish while GLMD’s TA Score has 4 bullish TA indicator(s).

  • CDIO’s TA Score: 4 bullish, 4 bearish.
  • GLMD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CDIO and GLMD are a good buy in the short-term.

Price Growth

CDIO (@Biotechnology) experienced а -26.09% price change this week, while GLMD (@Biotechnology) price change was -20.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.22%. For the same industry, the average monthly price growth was +3.03%, and the average quarterly price growth was +35.17%.

Reported Earning Dates

GLMD is expected to report earnings on Apr 01, 2026.

Industries' Descriptions

@Biotechnology (-4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLMD($3.67M) has a higher market cap than CDIO($2.48M). GLMD YTD gains are higher at: -10.726 vs. CDIO (-49.816). CDIO has higher annual earnings (EBITDA): -6.15M vs. GLMD (-7.11M). GLMD has more cash in the bank: 19.1M vs. CDIO (6.36M). GLMD has less debt than CDIO: GLMD (41K) vs CDIO (487K). CDIO has higher revenues than GLMD: CDIO (15.8K) vs GLMD (0).
CDIOGLMDCDIO / GLMD
Capitalization2.48M3.67M68%
EBITDA-6.15M-7.11M86%
Gain YTD-49.816-10.726464%
P/E RatioN/A0.02-
Revenue15.8K0-
Total Cash6.36M19.1M33%
Total Debt487K41K1,188%
FUNDAMENTALS RATINGS
GLMD: Fundamental Ratings
GLMD
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CDIOGLMD
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 14 days ago
68%
Bullish Trend 14 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CDIO
Daily Signal:
Gain/Loss:
GLMD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRNR0.480.01
+1.38%
Interactive Strength Inc
NEOG10.270.02
+0.20%
Neogen Corp
OHI42.93-0.09
-0.21%
Omega Healthcare Investors
MCS15.01-0.47
-3.04%
Marcus Corp (The)
ACET7.70-0.28
-3.51%
Adicet Bio Inc

CDIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDIO has been loosely correlated with KRRO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if CDIO jumps, then KRRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDIO
1D Price
Change %
CDIO100%
-6.21%
KRRO - CDIO
35%
Loosely correlated
-2.68%
CGTX - CDIO
27%
Poorly correlated
-1.75%
JAGX - CDIO
27%
Poorly correlated
-5.48%
LTRN - CDIO
27%
Poorly correlated
N/A
GLMD - CDIO
27%
Poorly correlated
+0.69%
More

GLMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLMD has been closely correlated with XBIO. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if GLMD jumps, then XBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLMD
1D Price
Change %
GLMD100%
+0.69%
XBIO - GLMD
88%
Closely correlated
-3.38%
VTVT - GLMD
33%
Loosely correlated
+7.52%
MGX - GLMD
33%
Loosely correlated
-3.25%
DNLI - GLMD
32%
Poorly correlated
-4.22%
GBIO - GLMD
31%
Poorly correlated
+1.06%
More